Based on results recently presented at the 2006 San Antonio Breast Cancer Symposium, researchers speculate that a sudden decrease in the incidence of breast cancer in 2003 may be due to a reduction in the use of postmenopausal hormone therapy.
Intelligent children are more likely to become vegetarians later in life, a study reported in the British Medical Journal. A Southampton University team found those who were vegetarian by 30 had recorded five IQ points more on average at the age of 10.
Every year there are potentially more than 500 sudden unexplained deaths in England, reveals a nationwide study published ahead of print in the journal Heart. This figure is around eight times higher than previously thought, the data suggest.
An analysis of previous studies suggests that for people with a history of vascular disease, folic acid supplementation does not decrease the risk of coronary heart disease or stroke, as has been suggested in some research, according to a review article in the December 13 issue of JAMA.
UK researchers have found that men who lose 3cm or more of height as they age have an increased risk of heart attack and death. The study, published in Archives of Internal Medicine, took into account other risk factors for heart disease and poor health.
Despite the death of Pfizer’s new cholesterol drug, researchers say they are not abandoning their quest to find ways to prevent heart disease by raising levels of “good” cholesterol. Reducing LDL, or “bad” cholesterol, has been the main focus of cardiology in recent years, but boosting its counterpart, HDL, also has a salutary effect.
New York city health officials are promising to be gentle when it comes to enforcing the first-in-the-nation ban on trans fats, which restaurants will have more than a year to rid from their food.
Thousands of statin users worldwide are suffering preventable heart attacks, simply because they are not complying with their treatment or are taking too low a dose, according to new research published on-line today (Thursday 7 December) in European Heart Journal.
The Food and Drug Administration (FDA) is warning five firms, Triangle Compounding Pharmacy, University Pharmacy, Custom Scripts Pharmacy, Hal?s Compounding Pharmacy, and New England Compounding Center, to stop compounding and distributing standardized versions of topical anesthetic creams, which are marketed for general distribution rather than responding to the unique medical needs of individual patients.
In testimony before the Food and Drug Administration (FDA), Gregory J. Dehmer, MD, president of the Society for Cardiovascular Angiography and Interventions (SCAI), today urged a review panel to evaluate new data on the safety of drug-eluting stents (DES) from the perspective of prior developments in the history of coronary intervention, and with an appreciation for the balance of benefits and risks that guides all clinical decision-making.